Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial Results Portfolio News / Karina Tin February 24, 2021 Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial Results Read More »
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update Portfolio News / Karina Tin February 16, 2021 Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update Read More »
Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Portfolio News / Karina Tin February 8, 2021 Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Read More »
Ribon Therapeutics Announces License Agreement with Ono Pharmaceutical Co., Ltd. to Develop and Commercialize RBN-2397 In Japan, South Korea, Taiwan and ASEAN Countries Portfolio News / Karina Tin February 2, 2021 Ribon Therapeutics Announces License Agreement with Ono Pharmaceutical Co., Ltd. to Develop and Commercialize RBN-2397 In Japan, South Korea, Taiwan and ASEAN Countries Read More »
